Follow
Françoise Van Bambeke
Title
Cited by
Cited by
Year
Antibiotic efflux pumps
F Van Bambeke, E Balzi, PM Tulkens
Biochemical pharmacology 60 (4), 457-470, 2000
6322000
Quinolones in 2005: an update
F Van Bambeke, JM Michot, J Van Eldere, PM Tulkens
Clinical Microbiology and infection 11 (4), 256-280, 2005
5322005
Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages
M Barcia-Macay, C Seral, MP Mingeot-Leclercq, PM Tulkens, ...
Antimicrobial agents and chemotherapy 50 (3), 841-851, 2006
3212006
Glycopeptide antibiotics: from conventional molecules to new derivatives
F Van Bambeke, Y Van Laethem, P Courvalin, PM Tulkens
Drugs 64, 913-936, 2004
2902004
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy
F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens
Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003
2782003
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux
F Van Bambeke, VJ Lee
Recent patents on anti-infective drug discovery 1 (2), 157-175, 2006
2432006
Intracellular Staphylococcus aureus persisters upon antibiotic exposure
F Peyrusson, H Varet, TK Nguyen, R Legendre, O Sismeiro, JY Coppée, ...
Nature communications 11 (1), 2200, 2020
2392020
Intracellular pharmacodynamics of antibiotics
S Carryn, H Chanteux, C Seral, MP Mingeot-Leclercq, F Van Bambeke, ...
Infectious Disease Clinics 17 (3), 615-634, 2003
2372003
Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against …
S Lemaire, PM Tulkens, F Van Bambeke
Antimicrobial agents and chemotherapy 55 (2), 649-658, 2011
2082011
Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
LG Garcia, S Lemaire, BC Kahl, K Becker, RA Proctor, O Denis, ...
Journal of antimicrobial chemotherapy 68 (7), 1455-1464, 2013
2022013
ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions
B Marquez, F Van Bambeke
Current drug targets 12 (5), 600-620, 2011
1942011
Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives
F Van Bambeke, M Barcia-Macay, S Lemaire, PM Tulkens
Current Opinion in Drug Discovery and Development 9 (2), 218, 2006
1922006
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus …
C Seral, F Van Bambeke, PM Tulkens
Antimicrobial agents and chemotherapy 47 (7), 2283-2292, 2003
1872003
The bacterial envelope as a target for novel anti-MRSA antibiotics
F Van Bambeke, MP Mingeot-Leclercq, MJ Struelens, PM Tulkens
Trends in pharmacological sciences 29 (3), 124-134, 2008
1752008
Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria
H Servais, P Van Der Smissen, G Thirion, G Van der Essen, ...
Toxicology and applied pharmacology 206 (3), 321-333, 2005
1752005
Glycopeptides in clinical development: pharmacological profile and clinical perspectives
F Van Bambeke
Current opinion in pharmacology 4 (5), 471-478, 2004
1672004
Comparative intracellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at …
S Carryn, F Van Bambeke, MP Mingeot-Leclercq, PM Tulkens
Antimicrobial agents and chemotherapy 46 (7), 2095-2103, 2002
1662002
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes
F Van Bambeke, PM Tulkens
Drug safety 32, 359-378, 2009
1652009
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options
F Van Bambeke, RR Reinert, PC Appelbaum, PM Tulkens, ...
Drugs 67, 2355-2382, 2007
1512007
A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms
J Bauer, W Siala, PM Tulkens, F Van Bambeke
Antimicrobial agents and chemotherapy 57 (6), 2726-2737, 2013
1502013
The system can't perform the operation now. Try again later.
Articles 1–20